1 – 152 of 152
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
2024) In Leukemia and Lymphoma(
- Contribution to journal › Article
-
Mark
Precision Diagnostics in Myeloid Malignancies : Development and Validation of a National Capture-Based Gene Panel
(
- Contribution to journal › Article
-
Mark
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hairy cell leukemia variant and WHO classification correspondence Re : 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
(
- Contribution to journal › Article
-
Mark
Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications
(
- Contribution to journal › Article
-
Mark
Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification
(
- Contribution to journal › Letter
-
Mark
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
(
- Contribution to journal › Article
- 2022
-
Mark
Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A risk score based on real-world data to predict early death in acute promyelocytic leukemia
(
- Contribution to journal › Article
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
(
- Contribution to journal › Article
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
(
- Contribution to journal › Article
- 2021
-
Mark
Combinatorial molecule screening identifies a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
(
- Contribution to journal › Article
-
Mark
Impact of treatment delay in acute myeloid leukemia revisited
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
(
- Contribution to journal › Scientific review
-
Mark
Epidemiology and Etiology of AML
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? : A population-based study
(
- Contribution to journal › Article
-
Mark
Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
(
- Contribution to journal › Article
-
Mark
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML : The HOVON-SAKK-132 trial
(
- Contribution to journal › Article
-
Mark
Subcutaneous cladribine to treat multiple sclerosis : experience in 208 patients
(
- Contribution to journal › Article
- 2020
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis
(
- Contribution to journal › Article
-
Mark
Decreasing early mortality in acute myeloid leukaemia in Sweden 1997–2014 : improving performance status is a major contributing factor
(
- Contribution to journal › Letter
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
(
- Contribution to journal › Article
-
Mark
Hypo, Hyper, or Combo : New paradigm for treatment of acute myeloid leukemia in older people
(
- Contribution to journal › Scientific review
-
Mark
Introducing patient-reported outcome in the acute leukemia quality registries in Sweden
(
- Contribution to journal › Article
-
Mark
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
(
- Contribution to journal › Letter
-
Mark
The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting
(
- Contribution to journal › Article
- 2019
-
Mark
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period
(
- Contribution to journal › Letter
-
Mark
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia : A Pooled Analysis of Individual Patient Data From Nine International Cohorts
(
- Contribution to journal › Article
-
Mark
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
(
- Contribution to journal › Article
-
Mark
Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma
(
- Contribution to journal › Article
- 2018
-
Mark
Subpopulations of T regulatory cells in blood stem cell harvests influence development of acute graft versus host disease in allogeneic transplant recipients
(
- Contribution to journal › Article
-
Mark
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
(
- Contribution to journal › Article
-
Mark
A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in very old patients
(
- Contribution to journal › Article
-
Mark
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology
(
- Contribution to journal › Article
-
Mark
A new genetic tool to improve immune-compromised mouse models : Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines
(
- Contribution to journal › Article
-
Mark
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy
(
- Contribution to journal › Letter
-
Mark
Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow
(
- Contribution to journal › Letter
- 2017
-
Mark
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
(
- Contribution to journal › Article
-
Mark
Incidence and prognostic significance of isolated trisomies in adult acute myeloid leukemia : A population-based study from the Swedish AML registry
(
- Contribution to journal › Article
-
Mark
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
(
- Contribution to journal › Scientific review
-
Mark
Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden
(
- Contribution to journal › Letter
-
Mark
Early death rates remain high in high-risk APL : Update from the Swedish Acute Leukemia Registry 1997-2013
(
- Contribution to journal › Letter
-
Mark
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells
(
- Contribution to journal › Article
-
Mark
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors : Shared and distinct immunogenetic features and clinical outcomes
(
- Contribution to journal › Article
-
Mark
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
(
- Contribution to journal › Article
-
Mark
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the nordic countries.
(
- Contribution to journal › Article
-
Mark
Small molecule screen identifies differentiation-promoting compounds targeting genetically diverse acute myeloid leukaemia.
(
- Contribution to journal › Article
-
Mark
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
(
- Contribution to journal › Article
-
Mark
Leukemia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Improved minimal residual disease detection by targeted quantitative polymerase chain reaction in Nucleophosmin 1 type a mutated acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
An open-label phase I dose-finding study of APR-246 in hematological malignancies
(
- Contribution to journal › Article
-
Mark
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia : The case of subset #2
(
- Contribution to journal › Article
- 2015
-
Mark
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
(
- Contribution to journal › Article
-
Mark
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
(
- Contribution to journal › Article
-
Mark
A pragmatic approach to dealing with fingolimod-related lynnphopaenia in Europe
(
- Contribution to journal › Letter
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
(
- Contribution to journal › Article
-
Mark
Prognostic significance of high hyperdiploid and tri-/tetraploid adult acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
(
- Contribution to journal › Article
-
Mark
Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
(
- Contribution to journal › Article
-
Mark
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
(
- Contribution to journal › Article
-
Mark
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
(
- Contribution to journal › Article
-
Mark
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.
(
- Contribution to journal › Letter
-
Mark
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.
(
- Contribution to journal › Article
-
Mark
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
2015) In Haematologica(
- Contribution to journal › Article
- 2014
-
Mark
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
(
- Contribution to journal › Article
-
Mark
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic
(
- Contribution to journal › Article
-
Mark
Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience.
(
- Contribution to journal › Article
-
Mark
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
(
- Contribution to journal › Letter
-
Mark
Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
(
- Contribution to journal › Article
-
Mark
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
(
- Contribution to journal › Article
- 2013
-
Mark
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
(
- Contribution to journal › Article
-
Mark
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
(
- Contribution to journal › Article
-
Mark
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
(
- Contribution to journal › Article
-
Mark
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
(
- Contribution to journal › Article
-
Mark
Globalization, Climate Change, and Human Health
(
- Contribution to journal › Letter
-
Mark
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients
(
- Contribution to journal › Article
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
(
- Contribution to journal › Article
-
Mark
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden : graft-versus-leukemia effect protects against relapse
(
- Contribution to journal › Article
- 2012
-
Mark
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study
(
- Contribution to journal › Letter
-
Mark
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
(
- Contribution to journal › Article
-
Mark
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
(
- Contribution to journal › Scientific review
-
Mark
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles
(
- Contribution to journal › Article
-
Mark
Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant
(
- Contribution to journal › Letter
-
Mark
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
(
- Contribution to journal › Article
-
Mark
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial
(
- Contribution to journal › Article
-
Mark
Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia
(
- Contribution to journal › Letter
-
Mark
IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
-
Mark
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in the real world: why population-based registries are needed.
(
- Contribution to journal › Article
- 2011
-
Mark
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder
(
- Contribution to journal › Article
-
Mark
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
(
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.
(
- Contribution to journal › Article
-
Mark
Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish acute leukemia registry.
(
- Contribution to journal › Article
-
Mark
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
(
- Contribution to journal › Article
-
Mark
'Hairy' cells: where are the roots of this leukemia?
(
- Contribution to journal › Article
-
Mark
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study.
(
- Contribution to journal › Letter
-
Mark
Hairy cell leukemia: epidemiology, pharmacokinetics of cladribine, and long-term follow-up of subcutaneous therapy.
(
- Contribution to journal › Article
-
Mark
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
(
- Contribution to journal › Article
-
Mark
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
(
- Contribution to journal › Article
-
Mark
Superior long-term survival with a high rate of allogeneic stem cell transplantation in AML (non-APL) patients below 60 years of age
2010) 36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting In Bone Marrow Transplantation 45. p.9-10(
- Contribution to journal › Published meeting abstract
-
Mark
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Population-based analyses in adult acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
Effective CD3 T-cell depletion using the CliniMacs (R) System to produce peripheral blood progenitor cell products for haploidentical transplantation in 23 children and adults: the updated Lund experience
2010) 36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting In Bone Marrow Transplantation 45(Suppl.2). p.325-325(
- Contribution to journal › Published meeting abstract
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
(
- Contribution to journal › Article
- 2009
-
Mark
Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.
(
- Contribution to journal › Published meeting abstract
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: A high-resolution genomic screening in newly diagnosed patients
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0354-0354(
- Contribution to journal › Published meeting abstract
-
Mark
Mechanisms of anti-cancer action and pharmacology of clofarabine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
(
- Contribution to journal › Published meeting abstract
-
Mark
Bendamustine in the Treatment of Chronic Lymphocytic Leukemia - Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups
(
- Contribution to journal › Published meeting abstract
-
Mark
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0355-0355(
- Contribution to journal › Published meeting abstract
-
Mark
Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.
(
- Contribution to journal › Article
-
Mark
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
(
- Contribution to journal › Article
- 2008
-
Mark
Screening For Copy-Number Alterations And Loss-Of-Heterozygosity In Chronic Lymphocytic Leukemia - A Comparative Study Of Four Differently Designed, High Resolution Microarray Platforms
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0536-0536(
- Contribution to journal › Published meeting abstract
-
Mark
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma - Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
(
- Contribution to journal › Article
-
Mark
Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
(
- Contribution to journal › Article
-
Mark
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-A comparative study of four differently designed, high resolution microarray platforms.
(
- Contribution to journal › Article
-
Mark
High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes
(
- Contribution to journal › Published meeting abstract
-
Mark
A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0209-0209(
- Contribution to journal › Published meeting abstract
-
Mark
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios.
(
- Contribution to journal › Article
- 2007
-
Mark
Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
(
- Contribution to journal › Article
- 2006
-
Mark
The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article
-
Mark
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
(
- Contribution to journal › Article
-
Mark
Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia.
(
- Contribution to journal › Article
- 2005
-
Mark
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
(
- Contribution to journal › Article
-
Mark
Monitoring oral cyclosporine therapy
(
- Contribution to journal › Letter
-
Mark
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
(
- Contribution to journal › Article
-
Mark
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Insamling av navelsträngsblod bör finansieras offentligt
(
- Contribution to journal › Letter
- 2004
-
Mark
Identification of a commonly amplified 4.3 Mb region with overexpression of the C8FW gene, encoding a phosphoprotein regulated by mitogenic pathways, but not of the MYC gene in MYC-containing double minutes in myeloid malignancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
(
- Contribution to journal › Article
- 2002
-
Mark
RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): Identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
(
- Contribution to journal › Letter